Global Liquid Biopsy Market Poised to Reach $7.6 Billion by 2030, Driven by Rising Cancer Cases and Technological Advancements

The global liquid biopsy market is projected to grow to USD 7,645.0 million by 2030, with a strong 20.3% annual growth rate, according to recent market analysis. The increasing adoption of non-invasive cancer detection methods, coupled with rising healthcare investments in emerging economies like India and China, is fueling this expansion.

The latest research report is dubbed as the first document encompassing the latest information about the Liquid Biopsy market that has been gravely affected by the COVID-19 pandemic. The global health crisis poses significant threats to the future growth of the Liquid Biopsy industry. The report assesses the profound changes in this business setting caused by the outbreak and considers the prominent market aspects that have been severely disrupted by the pandemic. The report thus expounds on the rapidly changing market scenario in this COVID-19 era, which aims to help businesses involved in this sector overcome the pandemic's gripping effects and formulate new growth strategies to boost the COVID-19 preparedness.

Request a Sample Report with Table of Contents and Figures to click Here: @https://www.emergenresearch.com/request-sample/34

What is Liquid Biopsy?

Liquid biopsy is a simple blood test that detects cancer markers without the need for invasive tissue biopsies. It provides faster results, reduces costs, and helps doctors monitor treatment effectiveness by tracking tumor DNA in the blood. This method is especially useful for patients who cannot undergo traditional biopsies or need frequent testing.

Key Market Drivers

Rising Cancer Cases - Increased tobacco and alcohol consumption worldwide has led to higher cancer rates, boosting demand for early detection tools like liquid biopsy.

Government & Private Investments - Growing funding for cancer research and advanced diagnostic technologies supports market growth.

Faster & More Affordable Testing - Compared to tissue biopsies, liquid biopsies are less expensive, quicker, and easier to repeat, making them a preferred choice for patients and doctors.

Challenges

Limited Awareness - Many developing regions still lack knowledge about liquid biopsy benefits.

Regulatory & Reimbursement Issues - Unclear policies in some countries may slow market adoption.

Competition from Traditional Methods - Solid biopsies and imaging techniques remain alternatives, though liquid biopsy is gaining traction.

To Customized Report Market: @https://www.emergenresearch.com/request-for-customization/34

Market Segmentation Highlights

By Product Type

Assay Kits Dominate - These ready-to-use testing kits are widely used in hospitals and clinics due to their convenience and accuracy.

By Biomarker Type

Circulating Tumor Cells (CTCs) - Expected to grow the fastest, as they help predict cancer progression and treatment response.

Circulating Tumor DNA (ctDNA) - Gaining popularity for detecting genetic mutations without repeated invasive biopsies.

By Sample Type

Blood Tests Lead the Market - Blood-based biopsies are painless, low-risk, and can detect multiple cancer markers.

Urine Tests Show Promise - A completely non-invasive option, ideal for frequent monitoring in high-risk patients.

By Technology

Next-Generation Sequencing (NGS) - Dominates due to its ability to detect multiple gene mutations at once.

PCR Testing - Growing for its speed and accuracy in diagnosing specific cancer-linked genes.

By Application

Early Cancer Screening - The largest segment, as liquid biopsies help detect cancer sooner, improving survival rates.

Treatment Monitoring - Doctors use these tests to check if therapies are working or if cancer has returned.

By End-User

Hospitals & Labs Lead Adoption - High patient volumes and advanced diagnostic facilities drive demand in this sector.

Future Outlook

With ongoing clinical trials and advancements in genetic testing, liquid biopsies are expected to become the standard for cancer detection, particularly for hard-to-diagnose cancers like pancreatic and brain tumors. The development of more sensitive and affordable tests will further accelerate market growth.

Key Market Competitors Profiled in the Report:

Bio-Rad Laboratories, Inc.

Adaptive Biotechnologies

NeoGenomics Laboratories

Guardant Health

Biocept, Inc.

QIAGEN

F. Hoffmann-La Roche Ltd.

MDxHealth

Menarini Silicon Biosystems

Agena Bioscience, Inc.

For More Details On this Report Click Here @https://www.emergenresearch.com/industry-report/liquid-biopsy-market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2020 and 2028. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Liquid Biopsy market on the basis of product, application, and region:

Liquid Biopsy Market Market Segmentation Analysis

For the purpose of this report, Emergen Research has segmented the global liquid biopsy market based on product type, circulating biomarkers, sample type, technology, disease, application, end-use, and region:

Product Type Outlook (Revenue, USD Million; 2019-2030)

Assays Kits

Instruments

Services

Circulating Biomarkers Outlook (Revenue, USD Million; 2019-2030)

Circulating Tumor DNA (ctDNA)

Circulating Tumor Cells (CTCs)

Extracellular Vesicles (EVs)

Cell-Free DNA (cfDNA)

Others

Sample Type Outlook (Revenue, USD Million; 2019-2030)

Blood Sample

Urine Sample

Others

Technology Outlook (Revenue, USD Million; 2019-2030)

Multi-gene-parallel Analysis (NGS)

Single Gene Analysis (PCR Microarrays)

Disease Outlook (Revenue, USD Million; 2019-2030)

Oncology

Breast Cancer

Lung Cancer

Prostate Cancer

Colorectal Cancer

Melanoma Cancer

Others

Non-cancer

Application Outlook (Revenue, USD Million; 2019-2030)

Early Cancer Screening

Therapy Selection

Treatment Monitoring

Recurrence Monitoring Orthopedics

End-Use Outlook (Revenue, USD Million; 2019-2030)

Hospitals & Physician Laboratories

Reference Laboratories

Academic & Research Centers

Others

Regional Analysis of the Liquid Biopsy Market:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Objectives of the Report:

Analysis and estimation of the Liquid Biopsy market size and share for the projected period of 2020-2027

Extensive analysis of the key players of the market by SWOT analysis and Porter's Five Forces analysis to impart a clear understanding of the competitive landscape

Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Liquid Biopsy market

Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments

Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Click Here To Buy Now @https://www.emergenresearch.com/select-license/34

Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.